KR20040059005A - Skin Whitening Cosmetic containing a herb extract with inhibitory activity of melanin formation - Google Patents

Skin Whitening Cosmetic containing a herb extract with inhibitory activity of melanin formation Download PDF

Info

Publication number
KR20040059005A
KR20040059005A KR1020020085528A KR20020085528A KR20040059005A KR 20040059005 A KR20040059005 A KR 20040059005A KR 1020020085528 A KR1020020085528 A KR 1020020085528A KR 20020085528 A KR20020085528 A KR 20020085528A KR 20040059005 A KR20040059005 A KR 20040059005A
Authority
KR
South Korea
Prior art keywords
extract
skin
jawan
skin whitening
melanin
Prior art date
Application number
KR1020020085528A
Other languages
Korean (ko)
Inventor
김청택
김호정
진무현
김원찬
강상진
Original Assignee
주식회사 엘지생활건강
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 엘지생활건강 filed Critical 주식회사 엘지생활건강
Priority to KR1020020085528A priority Critical patent/KR20040059005A/en
Publication of KR20040059005A publication Critical patent/KR20040059005A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/84Products or compounds obtained by lyophilisation, freeze-drying

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE: Provided is a skin whitening cosmetic containing, as an active ingredient, Aster tataricus extract having inhibiting effect on melanin generation. The Aster tataricus extract is a natural product and is thus applied to the skin safely without adverse effect. It is also inhibits the generation of melanin to prevent pigmentation on the skin. Therefore, the composition containing it is useful for discoloration on the face, freckles and skin whitening. CONSTITUTION: A skin whitening cosmetic composition is characterized by containing, as an active ingredient, 0.0001-10.0 wt.% of Aster tataricus extract, based on the total weight of the total weight of the composition, wherein the extraction solvent is selected from the group consisting of water, C1-4 lower alcohol, ethylacetate and acetone.

Description

멜라닌 생성 억제 활성을 갖는 식물 추출물을 함유하는 피부미백용 화장료 {Skin Whitening Cosmetic containing a herb extract with inhibitory activity of melanin formation}Skin whitening cosmetic containing a herb extract with inhibitory activity of melanin formation}

본 발명은 피부미백용 화장료에 관한 것으로서, 보다 상세하게는 피부에 대한 부작용 없이 안전하게 사용될 수 있으며 멜라닌 생성 억제 활성을 갖는 식물 추출물을 함유하는 피부미백용 화장료에 관한 것이다.The present invention relates to a skin whitening cosmetic, and more particularly to a skin whitening cosmetic containing a plant extract having a melanin production inhibitory activity can be used safely without side effects on the skin.

희고 고운 피부를 갖고자 하는 것은 모든 사람의 한결같은 소망이다. 사람의 피부색은 피부 내부의 멜라닌(melanin) 농도와 분포에 따라 결정되는데, 유전적인 요인 외에도, 태양 자외선이나 피로, 스트레스 등의 환경적 또는 생리적 조건에 의해서도 영향을 받는다. 멜라닌은 아미노산의 일종인 티로신(tyrosine)에 티로시나제(tyrosinase)라는 효소가 작용하여 도파(DOPA), 도파퀴논(dopaquinone)으로 바뀐 후 비효소적인 산화반응을 거쳐 만들어진다. 그러나, 멜라닌이 만들어지는 경로는 알려져 있지만, 티로시나제가 작용하는 이전 단계인 멜라닌 합성을 유도하는 메카니즘(mechanism)이 무엇인지에 대해서는 아직도 자세히 밝혀지지 않고 있다.It is everyone's constant desire to have white, fair skin. Human skin color is determined by the concentration and distribution of melanin in the skin. In addition to genetic factors, it is also influenced by environmental or physiological conditions such as ultraviolet rays, fatigue and stress. Melanin is a type of amino acid tyrosine (tyrosinase) acts as an enzyme called tyrosinase (tyrosinase) is converted to dopa (DOPA), dopaquinone (dopaquinone) is produced through a non-enzymatic oxidation reaction. However, although the pathway by which melanin is made is known, it is still not clear what mechanisms induce melanin synthesis, the previous step in which tyrosinase works.

이와 같은 멜라닌의 합성이 피부 내에서 과도하게 일어나면, 피부 톤을 어둡게 하고, 기미, 주근깨 등을 발생시키기기도 한다. 따라서, 피부내의 멜라닌 색소의 합성을 저해시키면, 피부 톤을 밝게 하여 피부 미백을 실현할 수 있을 뿐만 아니라 자외선, 호르몬 및 유전적인 원인에 기인하여 발생하는 기미, 주근깨 등의 피부 과색소 침착증을 개선시킬 수 있다.When such synthesis of melanin occurs excessively in the skin, it may darken the skin tone, and may cause spots and freckles. Therefore, by inhibiting the synthesis of melanin pigment in the skin, not only can brighten the skin tone to realize skin whitening, but also improve skin hyperpigmentation such as spots, freckles, etc. caused by ultraviolet rays, hormones and genetic causes. have.

따라서, 종래에는 하이드로퀴논(hydroquinone)이나 아스콜빈산(ascorbic acid), 코지산(kojic acid), 글루타티온(glutathione)과 같은 티로시나제에 대해 저해 활성을 갖는 물질을 연고, 에센스 등의 화장료에 배합하므로써 피부 미백을 실현하거나, 기미, 주근깨 등의 피부 과색소 침착증을 개선하였다. 그러나, 하이드로퀴논은 소정의 미백효과를 발휘하지만, 피부 자극성이 심하여 배합량을 극소량으로 제한해야 하는 문제점이 있고, 아스콜빈산은 산화되기 쉬워 이를 배합한 화장료는 변색, 변취되는 등의 문제가 발생하는 단점이 있다. 또한, 글루타티온, 시스테인 등의 티올계 화합물은 특유의 불쾌한 냄새를 가질 뿐만 아니라 경피흡수에도 문제점이 있고, 이들의 배당체 및 유도체들도 극성이 높으므로 화장료의 배합 성분으로 사용하기는 어렵다. 한편, 태반 추출물 등은 피부에 자극이 없으나, 미백 효과가 불충분하다.Therefore, conventionally, a substance having an inhibitory activity against tyrosinase, such as hydroquinone, ascorbic acid, kojic acid, glutathione, and the like, is formulated into a cosmetic such as an ointment or an essence. Whitening was realized or skin hyperpigmentation such as blemishes and freckles was improved. However, hydroquinone exhibits a predetermined whitening effect, but has a problem in that skin irritation is severe and the amount of the compound is limited to a very small amount, and ascorbic acid is easily oxidized, resulting in problems such as discoloration and discoloration. There is this. In addition, thiol-based compounds such as glutathione and cysteine not only have a characteristic unpleasant odor, but also have problems with transdermal absorption, and glycosides and derivatives thereof have high polarity, making it difficult to use as a cosmetic ingredient. Placenta extract, on the other hand, has no irritation to the skin, but lacks a whitening effect.

따라서, 본 발명이 이루고자 하는 기술적 과제는 상기 문제점을 해결하여 피부에 대한 부작용 없이 안전하게 사용될 수 있을 뿐만 아니라, 멜라닌 생성을 억제하여 색소 침착 저해 효과가 뛰어난 피부미백용 화장료를 제공하는데 있다.Therefore, the technical problem to be achieved by the present invention is to solve the above problems can be used safely without side effects on the skin, and to provide a cosmetic for skin whitening excellent in inhibiting the pigmentation effect by inhibiting the production of melanin.

상기 기술적 과제를 달성하기 위하여, 본 발명은 자완 추출물을 유효성분으로 함유하는 피부미백용 화장료를 제공한다.In order to achieve the above technical problem, the present invention provides a cosmetic for skin whitening containing Jawan extract as an active ingredient.

상기 자완 추출물의 함량은 화장료 총 중량을 기준으로 0.0001 내지 10.0중량%인 것이 바람직하다.The content of the Jawan extract is preferably 0.0001 to 10.0% by weight based on the total weight of the cosmetic.

또한, 상기 자완 추출물은 물, 탄소수 1 내지 4의 저급알코올, 에틸아세테이트 및 아세톤으로 이루어진 군에서 선택된 하나 이상의 용매로 추출하는 것이 바람직하며, 상기 용매로 가열추출 한 다음, 불용성 물질을 제거한 추출액을 감압증류하고 동결건조 또는 분사건조하는 것이 더욱 바람직하다.In addition, the Jawan extract is preferably extracted with one or more solvents selected from the group consisting of water, lower alcohols having 1 to 4 carbon atoms, ethyl acetate and acetone, heat extraction with the solvent, and then depressurize the extract liquid from which the insoluble substance is removed More preferred is distillation and lyophilization or spray drying.

이하, 본 발명에 따른 피부미백용 화장료를 상세히 설명한다.Hereinafter, the cosmetic for skin whitening according to the present invention will be described in detail.

본 발명에 따른 피부미백용 화장료에 함유된 자완은 국화과 식물인 자완(Aster tataricus L. f.), 연모자완(Aster souliei Franch)와 중관자완(Aster diplostephioides(DC) C. B. Clarke)의 뿌리와 뿌리줄기가 이용되며, 약리효과로는 거담, 진해, 항균, 항암작용이 있다고 보고되어 있다. 자완의 성분연구에 의하면 그 뿌리에는 에피프리델리놀(epifriedelinol), 프리델린(friedelin), 시오논(shionone), 애스터사포닌(astersaponin) 과 케르세틴(quercetine)이 들어 있고, 정유 중에는 라크노피롤(lachnophyllol), 라크노필롤 아세테이트(lachnophyllol acetate), 애니톨(anethole) 과 지방산 등이 함유되어 있는 것으로 알려져 있다 (중약대사전).Jawan contained in the skin whitening cosmetics according to the present invention is the root and root stem of Aster tataricus L. f., Aster souliei Franch and Aster diplostephioides (DC) CB Clarke It is reported that pharmacological effects include expectoration, antitussive, antibacterial and anticancer activity. Jawan's ingredient studies show that the roots contain epifriedelinol, friedelin, cionone, asteraponin and quercetine, and lacnopyrrole in essential oils. Lachnophyllol), lachnophyllol acetate, anethole and fatty acids are known to contain (Chinese medicinal dictionary).

이와 같이, 자완은 거담, 진해 및 항균 작용이 있는 한약재로 알려져 있으나, 본 발명자들은 자완의 추출물을 이용하여 멜라닌 합성 유도 자체를 억제하는물질까지 스크리닝(screening)할 수 있는 쥐의 멜라노마 세포(B16 mouse melanoma cell)를 대상으로 실험한 결과, 이들이 매우 강력한 멜라닌 생성 억제 효과 및 미백효과를 나타냄을 밝혀냈다. 따라서, 천연물질인 자완의 추출물을 피부외용 연고, 에센스, 크림 등의 화장료에 첨가하면 별다른 부작용 없이 강력한 피부 미백효과를 나타낼 수 있다.As described above, Jawan is known as an herbal medicine with expectoration, antitussive and antibacterial effects, but the present inventors can screen screening substances for inhibiting melanin synthesis induction by using Jawan extract (B16). Experiments with mouse melanoma cells revealed that they have very potent melanin inhibitory and whitening effects. Therefore, when the extract of Jawan, a natural substance, is added to cosmetics such as skin ointments, essences, creams, etc., it can exhibit a strong skin whitening effect without any side effects.

자완은 시중에서 쉽게 구입할 수 있는데, 자완의 추출물은 예를 들어, 자완을 물 또는 탄소수 1 내지 4의 무수 또는 함수 저급알코올 , 에틸아세테이트, 아세톤 등의 유기용매로 가열추출한 후, 감압 농축한 다음 동결건조 또는 분무건조하여 얻을 수 있다. 추출시, 자완을 잘게 분쇄하고, 물 또는 유기용매를 분쇄물 건조중량에 대해 5 내지 20부피가 되게 하여 50 내지 100℃에서 1 내지 5시간 가열하여 추출하는 것이 바람직하다. 고순도의 추출물을 얻으려면, 추출액을 같은 방법으로 1회 이상씩 더 추출할 수도 있다.Jawan can be easily purchased on the market. For example, Jawan extract can be extracted by heating with water or organic solvents such as anhydrous or hydrous lower alcohol having 1 to 4 carbon atoms, ethyl acetate, acetone, and then concentrated under reduced pressure and then frozen. It can be obtained by drying or spray drying. At the time of extraction, it is preferable to grind the chopped finely, and to extract water or an organic solvent by heating it at 50 to 100 DEG C for 1 to 5 hours by bringing the water or organic solvent to 5 to 20 volumes by weight of the dry matter. To obtain a high purity extract, the extract may be extracted one or more times in the same manner.

상기와 같이 얻어진 자완 추출물은 피부외용연고나 로션 같은 여러 화장료에 함유되어 사용될 수 있다. 본 발명에 따른 화장료 제조시에 함유되는 자완 추출물의 함량은 그 건조 중량이 화장료 총중량을 기준으로 0.0001 내지 10.0중량%인 것이 바람직하고, 더욱 바람직하게는 0.0005 내지 10.0중량%이다. 함량이 0.0001중량% 미만이면 뚜렷한 멜라닌 생성 억제 효과 및 미백효과를 기대하기 어려우며, 10.0중량%를 초과하면 증가하는 함유량만큼 뚜렷한 효과가 기대되지 않는다.Jawan extract obtained as described above may be used in a variety of cosmetics such as skin ointment or lotion. The content of the Jawan extract contained in the preparation of the cosmetic according to the present invention is preferably 0.0001 to 10.0% by weight, more preferably 0.0005 to 10.0% by weight, based on the total weight of the cosmetic. If the content is less than 0.0001% by weight, it is difficult to expect a clear melanin production inhibitory effect and a whitening effect, and when it exceeds 10.0% by weight, no clear effect is expected as the increasing content.

이하, 본 발명을 구체적으로 설명하기 위해 실시예를 들어 상세하게 설명하기로 한다. 그러나, 본 발명에 따른 실시예들은 여러 가지 다른 형태로 변형될 수있으며, 본 발명의 범위가 아래에서 상술하는 실시예들에 한정되는 것으로 해석되어져서는 안된다. 본 발명의 실시예들은 당업계에서 평균적인 지식을 가진 자에게 본 발명을 보다 완전하게 설명하기 위해서 제공되어지는 것이다.Hereinafter, the present invention will be described in detail with reference to Examples. However, embodiments according to the present invention may be modified in many different forms, and the scope of the present invention should not be construed as being limited to the embodiments described below. Embodiments of the present invention are provided to more completely explain the present invention to those skilled in the art.

자완 추출예Jawan Extraction Example

추출예 1Extraction Example 1

시판되는 자완을 구입하여 분쇄한 분쇄물 100g을 80% 메탄올 3ℓ에 투입하고, 냉각콘덴서가 달린 환류 추출기에서 3시간 동안 끓여 추출하였다. 이어서, 이 결과물을 100메쉬 여과포로 여과한 후, 잔사를 같은 방법으로 1회 더 추출하였다. 각각의 추출액을 합하여 상온에서 화트만(Whatman) 2번 여과지로 여과하여 불용성물질을 제거한 후, 냉각 콘덴서가 달린 증류장치에서 60℃로 감압농축한 후 동결건조하여 6.8g의 건조 추출물을 얻었다.Purchasing a commercially available Jawan was added 100 g of the ground pulverized product to 3 L of 80% methanol, and extracted by boiling for 3 hours in a reflux extractor equipped with a cooling capacitor. Subsequently, the resultant was filtered through a 100 mesh filter cloth, and the residue was extracted once more in the same manner. Each extract was combined and filtered using Whatman No. 2 filter paper at room temperature to remove insoluble materials, concentrated under reduced pressure at 60 ° C. in a distillation apparatus equipped with a cooling condenser, and lyophilized to obtain 6.8 g of dry extract.

추출예 2 ~ 6Extraction Example 2-6

80% 메탄올 대신 용매를 하기 표 1의 기재에 따라 변화시킨 것을 제외하고는 추출예 1과 동일한 방법으로 실시하였다.Except for changing the solvent according to the description in Table 1 instead of 80% methanol was carried out in the same manner as in Extraction Example 1.

용매menstruum 건조 추출물(g)Dry extract (g) 추출예 1Extraction Example 1 80% 메탄올80% methanol 6.86.8 추출예 2Extraction Example 2 정제수Purified water 7.57.5 추출예 3Extraction Example 3 85% 에탄올85% ethanol 5.55.5 추출예 4Extraction Example 4 70% 아세톤70% acetone 3.23.2 추출예 5Extraction Example 5 에틸아세테이트Ethyl acetate 3.73.7 추출예 6Extraction Example 6 포화노말부탄올Saturated normal butanol 5.45.4

실시예 1 ~ 6Examples 1-6

상기 추출예 1 내지 6에 따라 얻은 각각의 추출물과 하이드로퀴논 수용액을쥐의 멜라노마 세포(B-16 mouse melanoma cell)의 배양액에 첨가하여 세포수준에서의 미백 효과를 실험하였다(Lotan R., Lotan D. Cancer Res. 40:3345-3350, 1980). 추출예 1 내지 6에 따라 얻어진 각 추출물들을 최종농도가 0.005%가 되도록 하고(실시예 1 내지 6), 하이드로퀴논 수용액의 농도를 0.0001%로 하여 각각 B-16 멜라노마 세포의 배양배지에 첨가하여 3일간 배양한 후, 세포들을 트립신(trypsin)처리하여 배양용기로부터 떼어내 원심분리한 후 멜라닌을 추출하였다.Each of the extracts and the aqueous hydroquinone solution obtained according to the extraction examples 1 to 6 were added to the culture solution of mouse melanoma cells (B-16 mouse melanoma cells) to test the whitening effect at the cellular level (Lotan R., Lotan D. Cancer Res. 40: 3345-3350, 1980). Each of the extracts obtained in accordance with the extraction examples 1 to 6 to a final concentration of 0.005% (Examples 1 to 6), the hydroquinone aqueous solution was added to the culture medium of B-16 melanoma cells with a concentration of 0.0001% After incubation for 3 days, the cells were trypsin-treated and removed from the culture vessel and centrifuged to extract melanin.

여기에 수산화나트륨 용액(1N 농도) 1㎖를 가하여 10분간 끓여 멜라닌을 녹이고 분광 광도계를 이용, 400nm에서 흡광도를 측정하여 생성된 멜라닌의 양을 단위 세포수당(106cell) 흡광도로 나타내었다. 또한, 대조군에 대한 상대적인 멜라닌 생성량을 저해율(%)로 계산하여 그 결과를 하기 표 2에 나타냈다.Here are shown for 10 minutes to boil the amount of (10 6 cell) unit cell allowance of melanogenesis by measuring using a spectrophotometer, absorbance at 400nm was dissolved melanin absorbance was added to sodium hydroxide solution (1N concentration) 1㎖ hydroxide. In addition, the relative melanin production relative to the control was calculated as the inhibition rate (%) and the results are shown in Table 2 below.

시료sample 멜라닌 생성량Melanin production 저해율(%)% Inhibition 대조군(무첨가)Control group (no addition) 0.048±0.0030.048 ± 0.003 -- 실시예 1(최종농도 0.005%)Example 1 (final concentration 0.005%) 0.030±0.0030.030 ± 0.003 38%38% 실시예 2(최종농도 0.005%)Example 2 (final concentration 0.005%) 0.035±0.0020.035 ± 0.002 27%27% 실시예 3(최종농도 0.005%)Example 3 (final concentration 0.005%) 0.027±0.0020.027 ± 0.002 44%44% 실시예 4(최종농도 0.005%)Example 4 (final concentration 0.005%) 0.027±0.0020.027 ± 0.002 44%44% 실시예 5(최종농도 0.005%)Example 5 (final concentration 0.005%) 0.028±0.0030.028 ± 0.003 42%42% 실시예 6(최종농도 0.005%)Example 6 (final concentration 0.005%) 0.032±0.0030.032 ± 0.003 33%33%

*반복수 = 3* Repeat count = 3

표 2를 참조하면, 추출예 1 내지 6에 따라 얻어진 각 시료들은 대조군과 비교할 때 배양된 쥐의 멜라노마 세포에 대하여 매우 강력한 멜라닌 생성 억제능이 있음을 알 수 있을 뿐만 아니라(실시예 1~6), 전혀 정제되지 않은 추출물임을 감안하면 기존에 알려진 미백물질인 하이드로퀴논과 비교할 때도 그 효과가 크게 떨어지지 않음을 알 수 있다.Referring to Table 2, it can be seen that each sample obtained according to the extraction examples 1 to 6 has a very strong melanin production inhibitory ability against the melanoma cells of the cultured mice compared to the control group (Examples 1 to 6). Considering that it is an extract that is not purified at all, it can be seen that the effect is not significantly reduced when compared with hydroquinone, which is a previously known whitening substance.

실시예 7 ~ 10Examples 7-10

실시예 1과 같은 방법으로 배양된 쥐의 멜라노마 세포에 대하여 추출예 1의 추출물의 농도 변화에 따른 멜라닌 생성 억제능을 조사하였으며, 결과를 하기 표 3에 나타냈다.The melanin production inhibitory ability of the rat melanoma cells cultured in the same manner as in Example 1 according to the concentration change of the extract of Extraction Example 1 was investigated, and the results are shown in Table 3 below.

*반복수 = 3* Repeat count = 3

표 3의 결과에 나타난 바와 같이, 자완 추출물의 농도가 높아질 수록 배양된 쥐의 멜라노마 세포에 대하여 멜라닌 생성 억제능도 크게 향상됨을 알 수 있다.As shown in the results of Table 3, it can be seen that as the concentration of the Jawan extract is increased, the melanin production inhibitory ability is also greatly enhanced for the melanoma cells of the cultured rats.

한편, 하이드로퀴논은 강력한 멜라닌 생성 억제능을 가지지만 0.0001%의 저농도에서도 심한 세포 독성을 나타내나, 본 발명에 따른 천연식물의 추출물들은 0.05%농도 이상에서도 세포독성을 나타내지 않으므로 하이드로퀴논보다 높은 멜라닌 생성 억제 효과를 갖도록 할 수 있다.On the other hand, hydroquinone has a strong melanin production inhibitory ability, but exhibits severe cytotoxicity even at low concentration of 0.0001%, natural plant extracts according to the present invention does not show cytotoxicity even at 0.05% or more concentration, inhibiting melanin production higher than hydroquinone You can have an effect.

이하에서는, 자완 추출물을 피부 외용연고제, 크림, 유연화장수, 영양화장수, 팩, 에센스에 첨가하여 화장료를 제조하고, 피실험자를 대상으로 이들을 처방하여 나타난 색소침착 저해효과를 살펴 본다.In the following, the Jawan extract is added to the external skin ointment, cream, supple cosmetics, nutrient cosmetics, packs, essences to prepare the cosmetics, and examines the inhibitory effect of pigmentation appeared by prescribing them to the test subjects.

제조예 1Preparation Example 1

추출예 5로부터 얻은 자완 추출물을 유효성분으로 첨가하고, 하기 표 4에 기재된 성분과 함량으로 피부 외용연고제를 제조하였다.Jawan extract obtained from Extraction Example 5 was added as an active ingredient, and an external skin ointment was prepared using the ingredients and contents shown in Table 4 below.

비교예 1Comparative Example 1

식물 추출물을 첨가하지 않고, 하기 표 4에 기재된 성분과 함량으로 피부 외용연고제를 제조하였다.Without adding a plant extract, the skin external ointment was prepared with the ingredients and contents shown in Table 4 below.

조성물(중량%)Composition (% by weight) 제조예 1Preparation Example 1 비교예 1Comparative Example 1 자완 추출물Jawan Extract 1010 -- 디에틸 세바케이트Diethyl sebacate 88 88 경납Prepayment 55 55 폴리옥시에틸렌올레일에테르 포스페이트Polyoxyethylene oleyl ether phosphate 66 66 벤조산 나트륨Sodium benzoate 적량Quantity 적량Quantity 바셀린vaseline to 100to 100 to 100to 100

제조예 2Preparation Example 2

추출예 5로부터 얻은 자완 추출물을 각각 유효성분으로 첨가하고, 하기 표 5에 기재된 성분과 함량으로 크림을 제조하였다.Jawan extract obtained from Extraction Example 5 was added as an active ingredient, respectively, and a cream was prepared using the ingredients and contents shown in Table 5 below.

비교예 2Comparative Example 2

식물 추출물을 첨가하지 않고, 하기 표 5에 기재된 성분과 함량으로 크림을 제조하였다.Cream was prepared with the ingredients and contents shown in Table 5 below without the addition of plant extracts.

조성물(중량%)Composition (% by weight) 제조예 2Preparation Example 2 비교예 2Comparative Example 2 자완 추출물Jawan Extract 1.01.0 -- 스테아린산Stearic acid 15.015.0 15.015.0 세탄올Cetanol 1.01.0 1.01.0 수산화칼륨Potassium hydroxide 0.70.7 0.70.7 글리세린glycerin 5.05.0 5.05.0 프로필렌 글리콜Propylene glycol 3.03.0 3.03.0 방부제antiseptic 적량Quantity 적량Quantity incense 적량Quantity 적량Quantity 정제수Purified water to 100to 100 to 100to 100

제조예 3Preparation Example 3

추출예 5로부터 얻은 자완 추출물을 각각 유효성분으로 첨가하고, 하기 표 6에 기재된 성분과 함량으로 유연화장수를 제조하였다.Jawan extract obtained from the extraction example 5 was added as an active ingredient, respectively, to prepare a flexible longevity with the ingredients and contents shown in Table 6.

비교예 3Comparative Example 3

식물 추출물을 첨가하지 않고, 하기 표 6에 기재된 성분과 함량으로 유연화장수를 제조하였다.Without adding a plant extract, softening water was prepared with the ingredients and contents shown in Table 6.

조성물(중량%)Composition (% by weight) 제조예 3Preparation Example 3 비교예 3Comparative Example 3 자완 추출물Jawan Extract 0.20.2 -- 에탄올ethanol 10.010.0 10.010.0 폴리라우린산폴리옥시에틸렌소르비탄Polylauric acid polyoxyethylene sorbitan 1.01.0 1.01.0 파라옥시안식향산메틸Methyl paraoxybenzoate 0.20.2 0.20.2 글리세린glycerin 5.05.0 5.05.0 1,3-부틸렌글리콜1,3-butylene glycol 6.06.0 6.06.0 incense 적량Quantity 적량Quantity 색소Pigment 적량Quantity 적량Quantity 정제수Purified water to 100to 100 to 100to 100

제조예 4Preparation Example 4

추출예 5로부터 얻은 자완 추출물을 각각 유효성분으로 첨가하고, 하기 표 7에 기재된 성분과 함량으로 영양화장수를 제조하였다.Jawan extract obtained from Extraction Example 5 was added as an active ingredient, respectively, to prepare nutrient cosmetics with the ingredients and contents shown in Table 7 below.

비교예 4Comparative Example 4

식물 추출물을 첨가하지 않고, 하기 표 7에 기재된 성분과 함량으로 영양화장수를 제조하였다.No nutrient extract was prepared using the ingredients and contents shown in Table 7 below without adding a plant extract.

조성물(중량%)Composition (% by weight) 제조예 4Preparation Example 4 비교예 4Comparative Example 4 자완 추출물Jawan Extract 0.10.1 -- 와셀린Waselin 2.02.0 2.02.0 세스퀴올레인산소르비탄Sesquioleate sorbitan 0.80.8 0.80.8 폴리옥시에틸렌올레일에틸Polyoxyethylene oleylethyl 1.21.2 1.21.2 파라옥시안식향산메틸Methyl paraoxybenzoate 적량Quantity 적량Quantity 프로필렌글리콜Propylene glycol 5.05.0 5.05.0 에탄올ethanol 3.23.2 3.23.2 카르복시비닐폴리머Carboxy Vinyl Polymer 18.018.0 18.018.0 수산화칼륨Potassium hydroxide 0.10.1 0.10.1 색소Pigment 적량Quantity 적량Quantity incense 적량Quantity 적량Quantity 정제수Purified water to 100to 100 to 100to 100

제조예 5Preparation Example 5

추출예 5로부터 얻은 자완 추출물을 각각 유효성분으로 첨가하고, 하기 표 8에 기재된 성분과 함량으로 팩을 제조하였다.Jawan extract obtained from Extraction Example 5 was added as an active ingredient, and a pack was prepared with the ingredients and contents shown in Table 8 below.

비교예 5Comparative Example 5

식물 추출물을 첨가하지 않고, 하기 표 8에 기재된 성분과 함량으로 팩을 제조하였다.Packs were prepared with the ingredients and contents shown in Table 8 below without the addition of plant extracts.

조성물(중량%)Composition (% by weight) 제조예 5Preparation Example 5 비교예 5Comparative Example 5 자완 추출물Jawan Extract 0.50.5 -- 글리세린glycerin 5.05.0 5.05.0 프로필렌글리콜Propylene glycol 4.04.0 4.04.0 폴리비닐알코올Polyvinyl alcohol 15.015.0 15.015.0 에탄올ethanol 8.08.0 8.08.0 폴리옥시에틸렌올레일에틸Polyoxyethylene oleylethyl 1.01.0 1.01.0 파라옥시안식향산메틸Methyl paraoxybenzoate 0.20.2 0.20.2 incense 적량Quantity 적량Quantity 색소Pigment 적량Quantity 적량Quantity 정제수Purified water to 100to 100 to 100to 100

제조예 6Preparation Example 6

추출예 5로부터 얻은 자완 추출물을 각각 유효성분으로 첨가하고, 하기 표 9에 기재된 성분과 함량으로 에센스를 제조하였다.Jawan extract obtained from Extraction Example 5 was added as an active ingredient, and an essence was prepared according to the ingredients and contents shown in Table 9 below.

비교예 6Comparative Example 6

식물 추출물을 첨가하지 않고, 하기 표 9에 기재된 성분과 함량으로 에센스를 제조하였다.Essence was prepared with the ingredients and contents shown in Table 9 below without the addition of plant extracts.

조성물(중량%)Composition (% by weight) 제조예 6Preparation Example 6 비교예 6Comparative Example 6 자완 추출물Jawan Extract 55 -- 프로필렌글리콜Propylene glycol 10.010.0 10.010.0 글리세린glycerin 10.010.0 10.010.0 히알루론산나트륨수용액(1%)Sodium hyaluronate aqueous solution (1%) 5.05.0 5.05.0 에탄올ethanol 5.05.0 5.05.0 폴리옥시에틸렌경화피마자유Polyoxyethylene Cured Castor Oil 1.01.0 1.01.0 파라옥시안식향산메틸Methyl paraoxybenzoate 0.10.1 0.10.1 incense 적량Quantity 적량Quantity 정제수Purified water to 100to 100 to 100to 100

전술한 바와 같이 제조한 피부 외용연고제, 크림, 유연화장수, 영양화장수, 팩, 에센스에 의한 색소 침착 저해 효과를 검증하기 위해 사용한 방법은 다음과 같다.The method used to verify the pigmentation inhibitory effect by the skin external ointment, cream, supple cosmetics, nutrient cosmetics, pack, essence prepared as described above is as follows.

먼저, 건강한 남녀 20명씩을 선정하여 양팔의 하박부에 직경 7㎜ 크기의 구멍이 6개씩 2줄로 파인 알루미늄 호일을 붙이고, 팔에서 10㎝ 떨어진 거리에서 ORIEL solar simulaltor 1000W를 사용하여 60mJ/㎠의 광량을 조사하였다. 조사전에 70% 에탄올 수용액으로 조사부위를 잘 세척하였다. 조사하기 3일전부터 조사후 3주째까지 1일 2회씩 제조예 1 내지 6에 따라 제조된 자완 추출물을 함유하는 화장료와, 비교예 1 내지 6에 따라 식물 추출물이 함유되지 않은 기제를 한 쌍으로 같은 줄에 도포하였다. 여기서, 제조예 5 및 비교예 5의 팩제는 도포한 다음 15분 후에 떼어냈다.First, select 20 healthy men and women and attach aluminum foil with two rows of 6 holes with a diameter of 7 mm in the lower part of both arms. Was investigated. The irradiation site was washed well with 70% ethanol aqueous solution before irradiation. Two days a day from 3 days before irradiation to 3 weeks after irradiation, the cosmetic composition containing Jawan extract prepared according to Preparation Examples 1 to 6, and the base containing no plant extract according to Comparative Examples 1 to 6 were paired. It was applied to a string. Here, the pack agents of Preparation Example 5 and Comparative Example 5 were removed 15 minutes after the application.

상기 방법에 따라 각각의 제조예와 비교예에 따른 화장료를 처방한 후, 색소침착도를 육안으로 판정하고, 각 실시예에 따른 화장료와 비교예에 따른 화장료의 색소침착 억제 정도를 비교하여 뚜렷한 효과, 효과 있음, 차이 없음의 3단계로 평가하고, 아울러 피부 부작용 발생여부를 조사하여 그 결과를 하기 표 10에 나타냈다.After prescribing the cosmetics according to the respective production examples and comparative examples according to the above method, the degree of pigmentation was visually determined, and the effect of the pigmentation inhibition of the cosmetics according to each example and the cosmetics according to the comparative example was compared to the apparent effect. Evaluated in three stages, there is no effect, no difference, and also examined the occurrence of skin side effects are shown in Table 10 below.

실험물질Experimental substance 뚜렷한 효과(명)Distinct Effects (persons) 효과있음(명)Effective (persons) 차이없음(명)No difference (persons) 부작용(명)Side effects (persons) 제조예 1Preparation Example 1 44 88 88 00 제조예 2Preparation Example 2 33 66 1111 00 제조예 3Preparation Example 3 22 66 1212 00 제조예 4Preparation Example 4 22 77 1111 00 제조예 5Preparation Example 5 22 66 1212 00 제조예 6Preparation Example 6 33 88 99 00

상기 표 10에 나타난 바와 같이, 제조예 1 내지 6에 따라 제조된 자완 추출물이 함유된 화장료는 피시험자 20명중 최소 8명 이상이 피부 미백효과를 나타내었으며, 특히 많은 양의 자완 추출물이 함유된 제조예 1의 화장료는 식물 추출물이 함유되지 않은 비교예 1의 화장료보다 60%의 뚜렷한 색소 침착 저해 효과를 보이고 있으며, 피부내에 어떤 부작용도 나타나지 않았음을 알 수 있었다.As shown in Table 10, the cosmetic composition containing the Jawan extract prepared according to Preparation Examples 1 to 6 showed a skin whitening effect of at least 8 or more of 20 test subjects, especially a preparation containing a large amount of Jawan extract The cosmetic of Example 1 showed a clear pigmentation inhibitory effect of 60% than the cosmetic of Comparative Example 1 containing no plant extract, it was found that no side effects in the skin.

이와 같이 본 발명의 자완 추출물을 함유하는 피부미백용 화장료는 멜라닌 생성을 억제하여 색소 침착을 저해하므로 피부 미백 또는 기미나 주근깨 개선에 효과적이다. 또한, 자완은 천연물질이기 때문에 화장료로서 피부에 대한 부작용없이 안전하게 사용될 수 있다.As described above, the cosmetic for skin whitening containing the Jawan extract of the present invention inhibits melanin production and inhibits pigmentation, and thus is effective for improving skin whitening or freckles and freckles. In addition, because Jawan is a natural substance, it can be safely used as a cosmetic without side effects on the skin.

Claims (3)

자완 추출물을 유효성분으로 함유하는 것을 특징으로 하는 피부미백용 화장료.Cosmetics for skin whitening, characterized in that containing Jawan extract as an active ingredient. 제1항에 있어서, 상기 자완 추출물의 건조 중량이 화장료 총 중량을 기준으로 0.0001 내지 10.0중량%인 것을 특징으로 하는 피부미백용 화장료.The cosmetic composition for skin whitening according to claim 1, wherein the dry weight of the Jawan extract is 0.0001 to 10.0 wt% based on the total weight of the cosmetic. 제1항에 있어서, 상기 자완 추출물은 물, 탄소수 1 내지 4의 저급 알코올, 에틸아세테이트 및 아세톤으로 이루어진 군으로부터 선택된 하나 이상의 용매로 추출된 것을 특징으로 하는 피부미백용 화장료.The cosmetic composition for skin whitening according to claim 1, wherein the Jawan extract is extracted with one or more solvents selected from the group consisting of water, lower alcohols having 1 to 4 carbon atoms, ethyl acetate, and acetone.
KR1020020085528A 2002-12-27 2002-12-27 Skin Whitening Cosmetic containing a herb extract with inhibitory activity of melanin formation KR20040059005A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020020085528A KR20040059005A (en) 2002-12-27 2002-12-27 Skin Whitening Cosmetic containing a herb extract with inhibitory activity of melanin formation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020020085528A KR20040059005A (en) 2002-12-27 2002-12-27 Skin Whitening Cosmetic containing a herb extract with inhibitory activity of melanin formation

Publications (1)

Publication Number Publication Date
KR20040059005A true KR20040059005A (en) 2004-07-05

Family

ID=37351051

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020020085528A KR20040059005A (en) 2002-12-27 2002-12-27 Skin Whitening Cosmetic containing a herb extract with inhibitory activity of melanin formation

Country Status (1)

Country Link
KR (1) KR20040059005A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101143820B1 (en) * 2009-06-26 2012-05-04 대한민국(농촌진흥청장) Cosmetic composition comprising an extract of Aster ageratoides Turcz. var. ageratoides having whitening activities
CN104323958A (en) * 2014-11-14 2015-02-04 成都鹏翔生物科技有限公司 Natural sunscreen cream containing aster extracting resin
CN104398422A (en) * 2014-11-14 2015-03-11 成都鹏翔生物科技有限公司 Moistening oil-controlling face washing lotion containing aster tataricus extractive and preparation method thereof
KR20200125517A (en) * 2019-04-25 2020-11-04 제너럴바이오(주) COMPOSITION FOR SKIN WHITENING CONTAINING CALLUS EXTRACT FROM Aster yomena AND ITS CULTURE MEDIUM

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101143820B1 (en) * 2009-06-26 2012-05-04 대한민국(농촌진흥청장) Cosmetic composition comprising an extract of Aster ageratoides Turcz. var. ageratoides having whitening activities
CN104323958A (en) * 2014-11-14 2015-02-04 成都鹏翔生物科技有限公司 Natural sunscreen cream containing aster extracting resin
CN104398422A (en) * 2014-11-14 2015-03-11 成都鹏翔生物科技有限公司 Moistening oil-controlling face washing lotion containing aster tataricus extractive and preparation method thereof
CN104323958B (en) * 2014-11-14 2016-12-07 成都鹏翔生物科技有限公司 A kind of natural sun cream extracting resin containing Radix Asteris
KR20200125517A (en) * 2019-04-25 2020-11-04 제너럴바이오(주) COMPOSITION FOR SKIN WHITENING CONTAINING CALLUS EXTRACT FROM Aster yomena AND ITS CULTURE MEDIUM

Similar Documents

Publication Publication Date Title
KR100777554B1 (en) Composition for skin whitening containing Sitosterol
KR20010027448A (en) Cosmetic compositions
KR100544024B1 (en) Skin whitening compound
KR100454736B1 (en) Composition for skin whitening containing veratramine
KR100797367B1 (en) Cosmetic composition containing Veratrum nigrum L. extracts
KR100789632B1 (en) Cosmetic for skin whitening containing a herb extract with inhibitory activity of melanin formation
KR20050092313A (en) Skin whitening cosmetic containing a herb extract with inhibitory activity of melanin formation
KR100789634B1 (en) Cosmetic for skin whitening containing a herb extract with inhibitory activity of melanin formation
KR100466379B1 (en) Composition for skin whitening
KR100509848B1 (en) Composition for skin whitening
KR100757130B1 (en) Cosmetic for skin whitening containing verazine and epi-verazine with inhibitory activity of melanin formation
KR100797366B1 (en) Cosmetic composition containing Liquidambar taiwaniana Hance extracts and Cynanchum atratum Bunge extracts
KR20040059005A (en) Skin Whitening Cosmetic containing a herb extract with inhibitory activity of melanin formation
KR100789635B1 (en) Skin Whitening Cosmetic containing a herb extract with inhibitory activity of melanin formation
KR100431271B1 (en) Composition for skin whitening containing Arecoline
KR100789631B1 (en) Cosmetic for skin whitening containing a herb extract with inhibitory activity of melanin formation
KR20000020728A (en) Skin whitening composition
KR20050092314A (en) Skin whitening cosmetic containing a herb extract with inhibitory activity of melanin formation
KR19990048305A (en) Skin Whitening Composition
KR20040059007A (en) Skin Whitening Cosmetic containing a herb extract with inhibitory activity of melanin formation
KR19990085303A (en) Skin whitening material
KR100724168B1 (en) Cosmetic for skin whitening containing a herb extract with inhibitory activity of melanin formation
KR20020029184A (en) Cosmetic composition containing Acalypha australis L. extracts and Pterocarya stenoptera DC extracts
KR100770124B1 (en) Composition for skin whitening containing machilin-A
KR20040059006A (en) Skin Whitening Cosmetic containing a herb extract with inhibitory activity of melanin formation

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application